Insider Trades39 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | Sell | NTLA | Edward J Iii Dulac | EVP, Chief Financial Officer | 8,111 | $11.25 | $1.6B | -58.44% | +47.67% | $91.2K | -5.19% | — | Trim |
| Jul 2, 2026 | Sell | NTLA | Edward J Iii Dulac | EVP, Chief Financial Officer | 4,677 | $18.00 | $1.6B | -58.44% | +47.67% | $84.2K | -2.91% | 10b5-1 | Trim |
| Jul 1, 2026 | Sell | NTLA | Michael P Dube | VP, Chief Accounting Officer | 2,641 | $16.78 | $1.6B | -58.44% | +47.67% | $44.3K | -3.80% | — | Trim |
| Mar 2, 2026 | Sell | NTLA | Eliana Clark | EVP, Chief Technical Officer | 607 | $13.78 | $1.6B | -58.44% | +47.67% | $8.4K | -0.58% | — | Trim |
| Mar 2, 2026 | Sell | NTLA | James Basta | EVP, General Counsel | 1,211 | $13.78 | $1.6B | -58.44% | +47.67% | $16.7K | -0.54% | — | Trim |
| Jan 5, 2026 | Sell | NTLA | Michael P Dube | VP, Chief Accounting Officer | 2,989 | $9.21 | $1.6B | -58.44% | +47.67% | $27.5K | -5.41% | — | Trim |
| Jan 5, 2026 | Sell | NTLA | Edward J Iii Dulac | EVP, Chief Financial Officer | 6,379 | $9.21 | $1.6B | -58.44% | +47.67% | $58.8K | -6.01% | — | Trim |
| Jan 5, 2026 | Sell | NTLA | Birgit C Schultes | EVP, Chief Scientific Officer | 8,508 | $9.21 | $1.6B | -58.44% | +47.67% | $78.4K | -7.95% | — | Trim |
| Jan 5, 2026 | Sell | NTLA | Eliana Clark | EVP, Chief Technical Officer | 9,515 | $9.21 | $1.6B | -58.44% | +47.67% | $87.6K | -9.85% | — | Trim |
| Jan 5, 2026 | Sell | NTLA | James Basta | EVP, General Counsel | 10,397 | $9.21 | $1.6B | -58.44% | +47.67% | $95.8K | -9.29% | — | Trim |
| Jan 5, 2026 | Sell | NTLA | David Lebwohl | EVP, Chief Medical Officer | 11,903 | $9.21 | $1.6B | -58.44% | +47.67% | $109.6K | -8.94% | — | Trim |
| Jan 5, 2026 | Sell | NTLA | John M Leonard | President and CEO | 34,146 | $9.21 | $1.6B | -58.44% | +47.67% | $314.5K | -3.26% | — | Trim |
| Dec 11, 2025 | Sell | NTLA | John M Leonard | President and CEO | 146,662 | $8.43 | $1.6B | -58.44% | +47.67% | $1.2M | -0.55% | 10b5-1 | Trim |
| Oct 1, 2025 | Sell | NTLA | Birgit C Schultes | EVP, Chief Scientific Officer | 31 | $17.38 | $1.6B | -58.44% | +47.67% | $538.78 | -0.03% | — | Trim |
| Oct 1, 2025 | Sell | NTLA | Michael P Dube | VP, Chief Accounting Officer | 1,871 | $17.38 | $1.6B | -58.44% | +47.67% | $32.5K | -3.27% | — | Trim |
| Jul 23, 2025 | Sell | NTLA | Edward J Iii Dulac | EVP, Chief Financial Officer | 7,462 | $14.02 | $1.6B | -58.44% | +47.67% | $104.6K | -6.57% | — | Trim |
| Jul 2, 2025 | Sell | NTLA | Michael P Dube | VP, Chief Accounting Officer | 2,503 | $9.95 | $1.6B | -58.44% | +47.67% | $24.9K | -4.20% | — | Trim |
| Jul 1, 2025 | Sell | NTLA | Eliana Clark | EVP, Chief Technical Officer | 1,022 | $9.82 | $1.6B | -58.44% | +47.67% | $10.0K | -1.06% | — | Trim |
| Mar 4, 2025 | Sell | NTLA | Eliana Clark | EVP, Chief Technical Officer | 679 | $8.99 | $1.6B | -58.44% | +47.67% | $6.1K | -0.48% | — | Trim |
| Mar 4, 2025 | Sell | NTLA | James Basta | EVP, General Counsel | 2,572 | $8.99 | $1.6B | -58.44% | +47.67% | $23.1K | -1.50% | — | Trim |
| Jan 3, 2025 | Sell | NTLA | Michael P Dube | VP, Chief Accounting Officer | 1,372 | $12.18 | $1.6B | -58.44% | +47.67% | $16.7K | -2.92% | — | Trim |
| Jan 3, 2025 | Sell | NTLA | Derek Hicks | EVP, Chief Business Officer | 6,502 | $12.18 | $1.6B | -58.44% | +47.67% | $79.2K | -9.80% | — | Trim |
| Jan 3, 2025 | Sell | NTLA | James Basta | EVP, General Counsel | 7,074 | $12.18 | $1.6B | -58.44% | +47.67% | $86.2K | -8.67% | — | Trim |
| Jan 3, 2025 | Sell | NTLA | Laura Sepp-Lorenzino | EVP, Chief Scientific Officer | 8,966 | $12.18 | $1.6B | -58.44% | +47.67% | $109.2K | -10.38% | — | Trim |
| Jan 3, 2025 | Sell | NTLA | David Lebwohl | EVP, Chief Medical Officer | 9,557 | $12.18 | $1.6B | -58.44% | +47.67% | $116.4K | -9.83% | — | Trim |
| Jan 3, 2025 | Sell | NTLA | John M Leonard | President and CEO | 26,807 | $12.18 | $1.6B | -58.44% | +47.67% | $326.5K | -2.77% | — | Trim |
| Jan 2, 2025 | Sell | NTLA | Eliana Clark | EVP, Chief Technical Officer | 7,978 | $12.17 | $1.6B | -58.44% | +47.67% | $97.1K | -5.56% | — | Trim |
| Oct 2, 2024 | Sell | NTLA | Michael P Dube | VP, Chief Accounting Officer | 2,012 | $19.01 | $1.6B | -58.44% | +47.67% | $38.2K | -4.10% | — | Trim |
| Jul 1, 2024 | Sell | NTLA | Eliana Clark | EVP, Chief Technical Officer | 405 | $22.93 | $1.6B | -58.44% | +47.67% | $9.3K | -0.56% | — | Trim |
| Mar 4, 2024 | Sell | NTLA | Eliana Clark | EVP, Chief Technical Officer | 605 | $32.99 | $1.6B | -58.44% | +47.67% | $20.0K | -0.52% | — | Trim |
| Mar 4, 2024 | Sell | NTLA | James Basta | EVP, General Counsel | 2,297 | $32.99 | $1.6B | -58.44% | +47.67% | $75.8K | -1.76% | — | Trim |
| Jan 8, 2024 | Sell | NTLA | Laura Sepp-Lorenzino | EVP, Chief Scientific Officer | 2,275 | $28.87 | $1.6B | -58.44% | +47.67% | $65.7K | -2.51% | 10b5-1 | Trim |
| Jan 3, 2024 | Sell | NTLA | James Basta | EVP, General Counsel | 3,805 | $29.46 | $1.6B | -58.44% | +47.67% | $112.1K | -6.88% | — | Trim |
| Jan 3, 2024 | Sell | NTLA | Derek Hicks | EVP, Chief Business Officer | 3,877 | $29.46 | $1.6B | -58.44% | +47.67% | $114.2K | -9.49% | — | Trim |
| Jan 3, 2024 | Sell | NTLA | Eliana Clark | EVP, Chief Technical Officer | 4,608 | $29.50 | $1.6B | -58.44% | +47.67% | $136.0K | -5.09% | — | Trim |
| Jan 3, 2024 | Sell | NTLA | Glenn Goddard | EVP, Chief Financial Officer | 5,365 | $29.46 | $1.6B | -58.44% | +47.67% | $158.1K | -11.68% | — | Trim |
| Jan 3, 2024 | Sell | NTLA | Laura Sepp-Lorenzino | EVP, Chief Scientific Officer | 5,532 | $29.46 | $1.6B | -58.44% | +47.67% | $163.0K | -10.69% | — | Trim |
| Jan 3, 2024 | Sell | NTLA | David Lebwohl | EVP, Chief Medical Officer | 5,843 | $29.46 | $1.6B | -58.44% | +47.67% | $172.1K | -9.70% | — | Trim |
| Jan 3, 2024 | Sell | NTLA | John M Leonard | President and CEO | 19,223 | $29.46 | $1.6B | -58.44% | +47.67% | $566.3K | -2.22% | — | Trim |